Empagliflozin-Linagliptin
In stock
Description
Empaworth L 25/5 MG tablet is a combination medication used to treat Type 2 diabetes mellitus in adults. It combines Empagliflozin (25 mg), an SGLT2 inhibitor that removes excess sugar via urine, with Linagliptin (5 mg), a DPP-4 inhibitor that boosts insulin release, to improve glycemic control along with diet and exercise.
Specifications
| Strength | 3 mg |
|---|---|
| Main Igredients | Eszopiclone |
| Pack size | 1o Tablets |
| Packing | Strip |
| Shelf Life | 36 Months |
| Uses | Type 2 diabetes mellitus |
